-
1
-
-
33644800598
-
Prevalence of childhood epilepsy and distribution of epileptic syndromes: A population-based survey in Okayama, Japan
-
Oka E., Ohtsuka Y., Yoshinaga H., et al. Prevalence of childhood epilepsy and distribution of epileptic syndromes: A population-based survey in Okayama, Japan. Epilepsia 2006, 47:626-630.
-
(2006)
Epilepsia
, vol.47
, pp. 626-630
-
-
Oka, E.1
Ohtsuka, Y.2
Yoshinaga, H.3
-
2
-
-
0025954532
-
Prevalence of epilepsy in Rochester, Minnesota: 1940-80
-
Hauser W.A., Annegers J.F., Kurland L.T. Prevalence of epilepsy in Rochester, Minnesota: 1940-80. Epilepsia 1991, 32:429-445.
-
(1991)
Epilepsia
, vol.32
, pp. 429-445
-
-
Hauser, W.A.1
Annegers, J.F.2
Kurland, L.T.3
-
3
-
-
0029051911
-
Prevalence of epilepsy and epileptic seizures in 10 year old children: Results from the Metropolitan Atlanta Developmental Disabilities Study
-
Murphy C.C., Trevathan E., Yeargin-Allsopp M. Prevalence of epilepsy and epileptic seizures in 10 year old children: Results from the Metropolitan Atlanta Developmental Disabilities Study. Epilepsia 1995, 36:866-872.
-
(1995)
Epilepsia
, vol.36
, pp. 866-872
-
-
Murphy, C.C.1
Trevathan, E.2
Yeargin-Allsopp, M.3
-
4
-
-
0033863879
-
Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure
-
Shinnar S., Berg A.T., O'Dell C., et al. Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure. Ann Neurol 2000, 48:140-147.
-
(2000)
Ann Neurol
, vol.48
, pp. 140-147
-
-
Shinnar, S.1
Berg, A.T.2
O'Dell, C.3
-
5
-
-
0033821439
-
Epilepsy can be diagnosed when the first two seizures occur on the same day
-
Camfield P., Camfield C. Epilepsy can be diagnosed when the first two seizures occur on the same day. Epilepsia 2000, 41:1230-1233.
-
(2000)
Epilepsia
, vol.41
, pp. 1230-1233
-
-
Camfield, P.1
Camfield, C.2
-
6
-
-
37749044216
-
Special considerations for a first seizure in childhood and adolescence
-
Camfield P., Camfield C. Special considerations for a first seizure in childhood and adolescence. Epilepsia 2008, 49(suppl 1):40-44.
-
(2008)
Epilepsia
, vol.49
, Issue.SUPPL. 1
, pp. 40-44
-
-
Camfield, P.1
Camfield, C.2
-
7
-
-
60749087127
-
When to start drug treatment for childhood epilepsy: The clinical-epidemiological evidence
-
Arts W.F., Geerts A.T. When to start drug treatment for childhood epilepsy: The clinical-epidemiological evidence. Eur J Paediatr Neurol 2009, 13:93-101.
-
(2009)
Eur J Paediatr Neurol
, vol.13
, pp. 93-101
-
-
Arts, W.F.1
Geerts, A.T.2
-
8
-
-
0041386052
-
Vagus-nerve stimulation for the treatment of epilepsy
-
Ben-Menachem E. Vagus-nerve stimulation for the treatment of epilepsy. Lancet Neurol 2002, 1:477-482.
-
(2002)
Lancet Neurol
, vol.1
, pp. 477-482
-
-
Ben-Menachem, E.1
-
9
-
-
77953203585
-
Pediatric epilepsy surgery: looking back while moving forward
-
Donner E.J., Goodkin H.P. Pediatric epilepsy surgery: looking back while moving forward. Neurology 2010, 74:1756-1757.
-
(2010)
Neurology
, vol.74
, pp. 1756-1757
-
-
Donner, E.J.1
Goodkin, H.P.2
-
10
-
-
58149176094
-
First-drug treatment failures in children newly diagnosed with epilepsy
-
Dudley R.W., Penney S.J., Buckley D.J. First-drug treatment failures in children newly diagnosed with epilepsy. Pediatr Neurol 2009, 40:71-77.
-
(2009)
Pediatr Neurol
, vol.40
, pp. 71-77
-
-
Dudley, R.W.1
Penney, S.J.2
Buckley, D.J.3
-
11
-
-
34248589701
-
Prioritizing children's medicines for research: A pharmaco-epidemiological study of antiepileptic drugs
-
Ackers R., Murray M.L., Besag F.M., et al. Prioritizing children's medicines for research: A pharmaco-epidemiological study of antiepileptic drugs. Br J Clin Pharmacol 2007, 63:689-697.
-
(2007)
Br J Clin Pharmacol
, vol.63
, pp. 689-697
-
-
Ackers, R.1
Murray, M.L.2
Besag, F.M.3
-
13
-
-
70449730891
-
Lacosamide: an adjunctive agent for partial-onset seizures and potential therapy for neuropathic pain
-
Harris J.A., Murphy J.A. Lacosamide: an adjunctive agent for partial-onset seizures and potential therapy for neuropathic pain. Ann Pharmacother 2009, 43:1809-1817.
-
(2009)
Ann Pharmacother
, vol.43
, pp. 1809-1817
-
-
Harris, J.A.1
Murphy, J.A.2
-
14
-
-
37349071555
-
The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels
-
Errington A.C., Stöhr T., Heers C., et al. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol 2008, 73:157-169.
-
(2008)
Mol Pharmacol
, vol.73
, pp. 157-169
-
-
Errington, A.C.1
Stöhr, T.2
Heers, C.3
-
15
-
-
34247855780
-
Lacosamide: a review of preclinical properties
-
Beyreuther B.K., Freitag J., Heers C., et al. Lacosamide: a review of preclinical properties. CNS Drug Res 2007, 13:21-42.
-
(2007)
CNS Drug Res
, vol.13
, pp. 21-42
-
-
Beyreuther, B.K.1
Freitag, J.2
Heers, C.3
-
16
-
-
67649388104
-
Lacosamide: A new approach to target voltage-gated sodium currents in epileptic disorders
-
Curia G., Biagini G., Perucca E., et al. Lacosamide: A new approach to target voltage-gated sodium currents in epileptic disorders. CNS Drugs 2009, 23:555-568.
-
(2009)
CNS Drugs
, vol.23
, pp. 555-568
-
-
Curia, G.1
Biagini, G.2
Perucca, E.3
-
17
-
-
34447344551
-
Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures
-
Ben-Menachem E., Biton V., Jatuzis D., et al. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 2007, 48:1308-1317.
-
(2007)
Epilepsia
, vol.48
, pp. 1308-1317
-
-
Ben-Menachem, E.1
Biton, V.2
Jatuzis, D.3
-
18
-
-
33846194013
-
Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (Eilat. VIII)
-
Bialer M., Johannessen S.I., Kupferberg H.J., et al. Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (Eilat. VIII). Epilepsy Res 2007, 73:1-52.
-
(2007)
Epilepsy Res
, vol.73
, pp. 1-52
-
-
Bialer, M.1
Johannessen, S.I.2
Kupferberg, H.J.3
-
19
-
-
61849088333
-
Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial
-
Halasz P., Kälviäinen R., Mazurkiewicz-Beldzińska M., et al. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial. Epilepsia 2009, 50:443-453.
-
(2009)
Epilepsia
, vol.50
, pp. 443-453
-
-
Halasz, P.1
Kälviäinen, R.2
Mazurkiewicz-Beldzińska, M.3
-
20
-
-
77953033494
-
Lacosamide as adjunctive therapy for partial-onset seizures: A randomized controlled trial
-
Chung S., Sperling M.R., Biton V., et al. Lacosamide as adjunctive therapy for partial-onset seizures: A randomized controlled trial. Epilepsia 2010, 51:958-967.
-
(2010)
Epilepsia
, vol.51
, pp. 958-967
-
-
Chung, S.1
Sperling, M.R.2
Biton, V.3
-
21
-
-
70449533094
-
Six months of postmarketing experience with adjunctive lacosamide in patients with pharmacoresistant focal epilepsy at a tertiary epilepsy center in Germany
-
Wehner T., Bauer S., Hamer H.M., et al. Six months of postmarketing experience with adjunctive lacosamide in patients with pharmacoresistant focal epilepsy at a tertiary epilepsy center in Germany. Epilepsy Behav 2009, 16:423-425.
-
(2009)
Epilepsy Behav
, vol.16
, pp. 423-425
-
-
Wehner, T.1
Bauer, S.2
Hamer, H.M.3
-
22
-
-
17444446765
-
Preclinical characterization of MDL 27,192 as a potential broad spectrum anticonvulsant agent with neuroprotective properties
-
Kehne J.H., Kane M., Chaney S.F., et al. Preclinical characterization of MDL 27,192 as a potential broad spectrum anticonvulsant agent with neuroprotective properties. Epilepsy Res 1997, 27:41-54.
-
(1997)
Epilepsy Res
, vol.27
, pp. 41-54
-
-
Kehne, J.H.1
Kane, M.2
Chaney, S.F.3
-
23
-
-
59749093137
-
Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy
-
Kellinghaus C., Berning S., Besselmann M. Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy. Epilepsy Behav 2009, 14:429-431.
-
(2009)
Epilepsy Behav
, vol.14
, pp. 429-431
-
-
Kellinghaus, C.1
Berning, S.2
Besselmann, M.3
-
24
-
-
75649100509
-
Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide
-
Tilz C., Resch R., Hofer T., et al. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide. Epilepsia 2010, 51:316-317.
-
(2010)
Epilepsia
, vol.51
, pp. 316-317
-
-
Tilz, C.1
Resch, R.2
Hofer, T.3
-
25
-
-
39749167069
-
Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures
-
Biton V., Rosenfeld W.E., Whitesides J., et al. Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures. Epilepsia 2008, 49:418-424.
-
(2008)
Epilepsia
, vol.49
, pp. 418-424
-
-
Biton, V.1
Rosenfeld, W.E.2
Whitesides, J.3
-
26
-
-
4043070529
-
Diagnosis of infantile spasms, Lennox-Gastaut syndrome, and progressive myoclonic epilepsy
-
Shields W.D. Diagnosis of infantile spasms, Lennox-Gastaut syndrome, and progressive myoclonic epilepsy. Epilepsia 2004, 45(suppl 5):2-4.
-
(2004)
Epilepsia
, vol.45
, Issue.SUPPL. 5
, pp. 2-4
-
-
Shields, W.D.1
-
27
-
-
85129694326
-
Rufinamide: A novel broad-spectrum antiepileptic drug
-
Wheless J.W., Vazquez B. Rufinamide: A novel broad-spectrum antiepileptic drug. Epilepsy Curr 2010, 10:1-6.
-
(2010)
Epilepsy Curr
, vol.10
, pp. 1-6
-
-
Wheless, J.W.1
Vazquez, B.2
-
29
-
-
47249119666
-
The anticonvulsant profile of Rufinamide (CGP 33101) in rodent seizure models
-
White H.S., Franklin M.R., Kupferberg H.J., et al. The anticonvulsant profile of Rufinamide (CGP 33101) in rodent seizure models. Epilepsia 2008, 49:1213-1220.
-
(2008)
Epilepsia
, vol.49
, pp. 1213-1220
-
-
White, H.S.1
Franklin, M.R.2
Kupferberg, H.J.3
-
30
-
-
68149096743
-
Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: A randomized placebo-controlled trial
-
Brodie M.J., Rosenfeld W.E., Vazquez B., et al. Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: A randomized placebo-controlled trial. Epilepsia 2009, 50:1899-1909.
-
(2009)
Epilepsia
, vol.50
, pp. 1899-1909
-
-
Brodie, M.J.1
Rosenfeld, W.E.2
Vazquez, B.3
-
31
-
-
76049084221
-
A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of Rufinamide in adults and adolescents with inadequately controlled partial seizures
-
Elger C.E., Stefan H., Mann A., et al. A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of Rufinamide in adults and adolescents with inadequately controlled partial seizures. Epilepsy Res 2010, 88:255-263.
-
(2010)
Epilepsy Res
, vol.88
, pp. 255-263
-
-
Elger, C.E.1
Stefan, H.2
Mann, A.3
-
32
-
-
77952240784
-
First European long-term experience with the orphan drug rufinamide in childhood-onset refractory epilepsy
-
Kluger G., Haberlandt E., Kurlemann G., et al. First European long-term experience with the orphan drug rufinamide in childhood-onset refractory epilepsy. Epilepsy Behav 2010, 17:546-548.
-
(2010)
Epilepsy Behav
, vol.17
, pp. 546-548
-
-
Kluger, G.1
Haberlandt, E.2
Kurlemann, G.3
-
33
-
-
44949184519
-
Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome
-
Glauser T., Kluger G., Sachdeo R., et al. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology 2008, 70:1950-1958.
-
(2008)
Neurology
, vol.70
, pp. 1950-1958
-
-
Glauser, T.1
Kluger, G.2
Sachdeo, R.3
-
34
-
-
75149122341
-
Safety and tolerability of rufinamide in children with epilepsy: A pooled analysis of 7 clinical studies
-
Wheless J.W., Conry J., Krauss G., et al. Safety and tolerability of rufinamide in children with epilepsy: A pooled analysis of 7 clinical studies. J Child Neurol 2009, 24:1520-1525.
-
(2009)
J Child Neurol
, vol.24
, pp. 1520-1525
-
-
Wheless, J.W.1
Conry, J.2
Krauss, G.3
-
35
-
-
33746111455
-
The effect of the new antiepileptic drug rufinamide on cognitive functions
-
Aldenkamp A.P., Alpherts W.C. The effect of the new antiepileptic drug rufinamide on cognitive functions. Epilepsia 2006, 47:1153-1159.
-
(2006)
Epilepsia
, vol.47
, pp. 1153-1159
-
-
Aldenkamp, A.P.1
Alpherts, W.C.2
-
36
-
-
51449119865
-
Pharmacological management of epilepsy: Recent advances and future prospects
-
Johannessen Landmark C., Johannessen S.I. Pharmacological management of epilepsy: Recent advances and future prospects. Drugs 2008, 68:1925-1939.
-
(2008)
Drugs
, vol.68
, pp. 1925-1939
-
-
Johannessen Landmark, C.1
Johannessen, S.I.2
-
37
-
-
77949266502
-
Supporting the recommended paediatric dosing regimen for rufinamide in Lennox-Gastaut syndrome using clinical trial simulation
-
Marchand M., Fuseau E., Critchley D.J. Supporting the recommended paediatric dosing regimen for rufinamide in Lennox-Gastaut syndrome using clinical trial simulation. J Pharmacokinet Pharmacodyn 2010, 37:99-118.
-
(2010)
J Pharmacokinet Pharmacodyn
, vol.37
, pp. 99-118
-
-
Marchand, M.1
Fuseau, E.2
Critchley, D.J.3
-
39
-
-
0032977994
-
Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures
-
Petroff O.A., Hyder F., Collins T., et al. Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures. Epilepsia 1999, 40:958-964.
-
(1999)
Epilepsia
, vol.40
, pp. 958-964
-
-
Petroff, O.A.1
Hyder, F.2
Collins, T.3
-
40
-
-
0035940574
-
Randomized trial of vigabatrin in patients with infantile spasms
-
Elterman R.D., Shields W.D., Mansfield K.A., et al. Randomized trial of vigabatrin in patients with infantile spasms. Neurology 2001, 57:1416-1421.
-
(2001)
Neurology
, vol.57
, pp. 1416-1421
-
-
Elterman, R.D.1
Shields, W.D.2
Mansfield, K.A.3
-
41
-
-
47249112141
-
Vigabatrin in the treatment of childhood epilepsy: A retrospective chart review of efficacy and safety profile
-
Camposano S.E., Major P., Halpern E., et al. Vigabatrin in the treatment of childhood epilepsy: A retrospective chart review of efficacy and safety profile. Epilepsia 2008, 49:1186-1191.
-
(2008)
Epilepsia
, vol.49
, pp. 1186-1191
-
-
Camposano, S.E.1
Major, P.2
Halpern, E.3
-
43
-
-
26844507605
-
The United Kingdom infantile spasms Study (UKISS): Comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: A multicentre randomised trial
-
Lux A.L., Edwards S.W., Hancock E., et al. The United Kingdom infantile spasms Study (UKISS): Comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: A multicentre randomised trial. Lancet Neurol 2005, 4:712-717.
-
(2005)
Lancet Neurol
, vol.4
, pp. 712-717
-
-
Lux, A.L.1
Edwards, S.W.2
Hancock, E.3
-
44
-
-
8444249008
-
The United Kingdom Infantile Spasms Study: Comparing vigabatrin with prednisolone or tetracosactide at 14 days: A multicentre, randomised controlled trial
-
Lux A.L., Edwards S.W., Hancock E., et al. The United Kingdom Infantile Spasms Study: Comparing vigabatrin with prednisolone or tetracosactide at 14 days: A multicentre, randomised controlled trial. Lancet 2004, 364:1773-1778.
-
(2004)
Lancet
, vol.364
, pp. 1773-1778
-
-
Lux, A.L.1
Edwards, S.W.2
Hancock, E.3
-
45
-
-
77953741161
-
Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: A multi-centre randomised trial
-
Darke K., Edwards S.W., Hancock E., et al. Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: A multi-centre randomised trial. Arch Dis Child 2010, 95:382-386.
-
(2010)
Arch Dis Child
, vol.95
, pp. 382-386
-
-
Darke, K.1
Edwards, S.W.2
Hancock, E.3
-
46
-
-
62849105099
-
Multicenter long-term follow-up of children with idiopathic West syndrome: ACTH versus vigabatrin
-
Cohen-Sadan S., Kramer U., Ben-Zeev B., et al. Multicenter long-term follow-up of children with idiopathic West syndrome: ACTH versus vigabatrin. Eur J Neurol 2009, 16:482-487.
-
(2009)
Eur J Neurol
, vol.16
, pp. 482-487
-
-
Cohen-Sadan, S.1
Kramer, U.2
Ben-Zeev, B.3
-
48
-
-
0029997934
-
A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures. Vigabatrin Protocol 024 Investigative Cohort
-
French J.A., Mosier M., Walker S., et al. A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures. Vigabatrin Protocol 024 Investigative Cohort. Neurology 1996, 46:54-61.
-
(1996)
Neurology
, vol.46
, pp. 54-61
-
-
French, J.A.1
Mosier, M.2
Walker, S.3
-
49
-
-
0032947717
-
Dose-response study of vigabatrin as add-on therapy in patients with uncontrolled complex partial seizures
-
Dean C., Mosier M., Penry K. Dose-response study of vigabatrin as add-on therapy in patients with uncontrolled complex partial seizures. Epilepsia 1999, 40:74-82.
-
(1999)
Epilepsia
, vol.40
, pp. 74-82
-
-
Dean, C.1
Mosier, M.2
Penry, K.3
-
50
-
-
0344118227
-
Vigabatrin, a GABAergic antiepileptic drug, causes concentric visual field defects
-
Kalviainen R., Nousiainen I., Mäntyjärvi M., et al. Vigabatrin, a GABAergic antiepileptic drug, causes concentric visual field defects. Neurology 1999, 53:922-926.
-
(1999)
Neurology
, vol.53
, pp. 922-926
-
-
Kalviainen, R.1
Nousiainen, I.2
Mäntyjärvi, M.3
-
51
-
-
0032762648
-
Characteristics of a unique visual field defect attributed to vigabatrin
-
Wild J.M., Martinez C., Reinshagen G., et al. Characteristics of a unique visual field defect attributed to vigabatrin. Epilepsia 1999, 40:1784-1794.
-
(1999)
Epilepsia
, vol.40
, pp. 1784-1794
-
-
Wild, J.M.1
Martinez, C.2
Reinshagen, G.3
-
52
-
-
0032763649
-
Visual dysfunction in patients receiving vigabatrin: Clinical and electrophysiologic findings
-
Miller N.R., Johnson M.A., Paul S.R., et al. Visual dysfunction in patients receiving vigabatrin: Clinical and electrophysiologic findings. Neurology 1999, 53:2082-2087.
-
(1999)
Neurology
, vol.53
, pp. 2082-2087
-
-
Miller, N.R.1
Johnson, M.A.2
Paul, S.R.3
-
53
-
-
77749276685
-
Evaluating risks for vigabatrin treatment
-
Krauss G.L. Evaluating risks for vigabatrin treatment. Epilepsy Curr 2009, 9:125-129.
-
(2009)
Epilepsy Curr
, vol.9
, pp. 125-129
-
-
Krauss, G.L.1
-
54
-
-
58849147016
-
Cerebral MRI abnormalities associated with vigabatrin therapy
-
Pearl P.L., Vezina L.G., Saneto R.P., et al. Cerebral MRI abnormalities associated with vigabatrin therapy. Epilepsia 2009, 50:184-194.
-
(2009)
Epilepsia
, vol.50
, pp. 184-194
-
-
Pearl, P.L.1
Vezina, L.G.2
Saneto, R.P.3
-
55
-
-
62149125476
-
Transient brain magnetic resonance imaging hyperintensity in basal ganglia and brain stem of epileptic infants treated with vigabatrin
-
Milh M., Villeneuve N., Chapon F., et al. Transient brain magnetic resonance imaging hyperintensity in basal ganglia and brain stem of epileptic infants treated with vigabatrin. J Child Neurol 2009, 24:305-315.
-
(2009)
J Child Neurol
, vol.24
, pp. 305-315
-
-
Milh, M.1
Villeneuve, N.2
Chapon, F.3
-
56
-
-
58849112158
-
Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy
-
Wheless J.W., Carmant L., Bebin M., et al. Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy. Epilepsia 2009, 50:195-205.
-
(2009)
Epilepsia
, vol.50
, pp. 195-205
-
-
Wheless, J.W.1
Carmant, L.2
Bebin, M.3
-
57
-
-
59449092002
-
Refinement of the binding site and mode of action of the anticonvulsant retigabine on KCNQ K+ channels
-
Lange W., Geissendörfer J., Schenzer A., et al. Refinement of the binding site and mode of action of the anticonvulsant retigabine on KCNQ K+ channels. Mol Pharmacol 2009, 75:272-280.
-
(2009)
Mol Pharmacol
, vol.75
, pp. 272-280
-
-
Lange, W.1
Geissendörfer, J.2
Schenzer, A.3
-
58
-
-
0033862433
-
Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels
-
Wickenden A.D., Yu W., Zou A., et al. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. Mol Pharmacol 2000, 58:591-600.
-
(2000)
Mol Pharmacol
, vol.58
, pp. 591-600
-
-
Wickenden, A.D.1
Yu, W.2
Zou, A.3
-
59
-
-
77953317302
-
Retigabine: The newer potential antiepileptic drug
-
Czuczwar P., Wojtak A., Cioczek-Czuczwar A., et al. Retigabine: The newer potential antiepileptic drug. Pharmacol Rep 2010, 62:211-219.
-
(2010)
Pharmacol Rep
, vol.62
, pp. 211-219
-
-
Czuczwar, P.1
Wojtak, A.2
Cioczek-Czuczwar, A.3
-
60
-
-
34247252905
-
Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures
-
Porter R.J., Partiot A., Sachdeo R., et al. Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures. Neurology 2007, 68:1197-1204.
-
(2007)
Neurology
, vol.68
, pp. 1197-1204
-
-
Porter, R.J.1
Partiot, A.2
Sachdeo, R.3
-
61
-
-
57849141134
-
Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (Eilat IX)
-
Bialer M., Johannessen S.I., Levy R.H., et al. Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (Eilat IX). Epilepsy Res 2009, 83:1-43.
-
(2009)
Epilepsy Res
, vol.83
, pp. 1-43
-
-
Bialer, M.1
Johannessen, S.I.2
Levy, R.H.3
-
62
-
-
70350144535
-
Deletions involving both KCNQ2 and CHRNA4 present with benign familial neonatal seizures
-
Kurahashi H., Wang J.W., Ishii A., et al. Deletions involving both KCNQ2 and CHRNA4 present with benign familial neonatal seizures. Neurology 2009, 73:1214-1217.
-
(2009)
Neurology
, vol.73
, pp. 1214-1217
-
-
Kurahashi, H.1
Wang, J.W.2
Ishii, A.3
-
63
-
-
84875833269
-
Benign familial neonatal seizures
-
University of Washington, Seattle, WA, B. Stephens, R.A. Pagan, C.R. Dolan (Eds.)
-
Bellini G., Miceli F., Soldovieri M.V. Benign familial neonatal seizures. GeneReviews 2010, University of Washington, Seattle, WA. B. Stephens, R.A. Pagan, C.R. Dolan (Eds.).
-
(2010)
GeneReviews
-
-
Bellini, G.1
Miceli, F.2
Soldovieri, M.V.3
-
64
-
-
49549119738
-
Brivaracetam: A rational drug discovery success story
-
Rogawski M.A. Brivaracetam: A rational drug discovery success story. Br J Pharmacol 2008, 154:1555-1557.
-
(2008)
Br J Pharmacol
, vol.154
, pp. 1555-1557
-
-
Rogawski, M.A.1
-
65
-
-
32544452985
-
Synaptic vesicle protein 2 enhances release probability at quiescent synapses
-
Custer K.L., Austin N.S., Sullivan J.M., et al. Synaptic vesicle protein 2 enhances release probability at quiescent synapses. J Neurosci 2006, 26:1303-1313.
-
(2006)
J Neurosci
, vol.26
, pp. 1303-1313
-
-
Custer, K.L.1
Austin, N.S.2
Sullivan, J.M.3
-
66
-
-
34548397130
-
Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model
-
Kasteleijn-Nolst Trenite D.G., Genton P., Parain D., et al. Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model. Neurology 2007, 69:1027-1034.
-
(2007)
Neurology
, vol.69
, pp. 1027-1034
-
-
Kasteleijn-Nolst Trenite, D.G.1
Genton, P.2
Parain, D.3
-
67
-
-
42549127137
-
Efficacy and tolerability of 5 20, 50 mg/day Brivaracetam (UCB 34714) as adjunctive treatment in adults with refractory partial-onset seizures
-
Brivaracetam N01193 Study Group
-
French J.A., Von Rosenstiel P. Efficacy and tolerability of 5 20, 50 mg/day Brivaracetam (UCB 34714) as adjunctive treatment in adults with refractory partial-onset seizures. Epilepsia 2007, 48:400. Brivaracetam N01193 Study Group.
-
(2007)
Epilepsia
, vol.48
, pp. 400
-
-
French, J.A.1
Von Rosenstiel, P.2
-
68
-
-
42549143839
-
Efficacy and tolerability of 50 and 150 mg/day Brivaracetam (UCB 34714) as adjunctive treatment in adults with refractory partial-onset epilepsy
-
b.o.t.B.N.S.G.
-
van Paesschen W. Efficacy and tolerability of 50 and 150 mg/day Brivaracetam (UCB 34714) as adjunctive treatment in adults with refractory partial-onset epilepsy. Epilepsia 2007, 48:329. b.o.t.B.N.S.G.,.
-
(2007)
Epilepsia
, vol.48
, pp. 329
-
-
van Paesschen, W.1
-
69
-
-
78650298362
-
-
Accessed November 1, 2010
-
Accessed November 1, 2010. http://professionals.epilepsy.com/page/announce_42909.html.
-
-
-
-
70
-
-
42549172614
-
Safety and tolerability of Brivaracetam (UCB 34714) as adjunctive treatment in adults with refractory partial-onset seizures
-
Brodsky A., von Rosenstiel P. Safety and tolerability of Brivaracetam (UCB 34714) as adjunctive treatment in adults with refractory partial-onset seizures. Epilepsia 2008, 48:342.
-
(2008)
Epilepsia
, vol.48
, pp. 342
-
-
Brodsky, A.1
von Rosenstiel, P.2
-
71
-
-
78650280401
-
-
Accessed November 10, 2010
-
Accessed November 10, 2010. http://www.lundbeck.com/investor/releases/ReleaseDetails/Release_1418334_EN.asp.
-
-
-
-
72
-
-
0034108997
-
Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype
-
McKernan R.M., Rosahl T.W., Reynolds D.S., et al. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci 2000, 3:587-592.
-
(2000)
Nat Neurosci
, vol.3
, pp. 587-592
-
-
McKernan, R.M.1
Rosahl, T.W.2
Reynolds, D.S.3
-
74
-
-
44949114187
-
Clobazam as an add-on in the management of refractory epilepsy
-
CD004154
-
Michael B. Clobazam as an add-on in the management of refractory epilepsy. Cochrane Database Syst Rev 2008, 16. CD004154.
-
(2008)
Cochrane Database Syst Rev
, vol.16
-
-
Michael, B.1
-
75
-
-
17144474677
-
Clobazam has equivalent efficacy to carbamazepinephenytoin as monotherapy for childhood epilepsy: Canadian Study Group for Childhood Epilepsy
-
Clobazam has equivalent efficacy to carbamazepinephenytoin as monotherapy for childhood epilepsy: Canadian Study Group for Childhood Epilepsy. Epilepsia 1998, 39:952-959.
-
(1998)
Epilepsia
, vol.39
, pp. 952-959
-
-
-
76
-
-
0023206004
-
Clobazam in therapy-resistant patients with partial epilepsy: A double-blind placebo-controlled crossover study
-
Koeppen D., Baruzzi A., Capozza M., et al. Clobazam in therapy-resistant patients with partial epilepsy: A double-blind placebo-controlled crossover study. Epilepsia 1987, 28:495-506.
-
(1987)
Epilepsia
, vol.28
, pp. 495-506
-
-
Koeppen, D.1
Baruzzi, A.2
Capozza, M.3
-
77
-
-
0025124844
-
Clobazam as an add-on drug in the treatment of refractory epilepsy of childhood
-
Keene D.L., Whiting S., Humphreys P. Clobazam as an add-on drug in the treatment of refractory epilepsy of childhood. Can J Neurol Sci 1990, 17:317-319.
-
(1990)
Can J Neurol Sci
, vol.17
, pp. 317-319
-
-
Keene, D.L.1
Whiting, S.2
Humphreys, P.3
-
78
-
-
77953217352
-
Epileptogenesis provoked by prolonged experimental febrile seizures: Mechanisms and biomarkers
-
Dube C.M., Ravizza T., Hamamura M., et al. Epileptogenesis provoked by prolonged experimental febrile seizures: Mechanisms and biomarkers. J Neurosci 2010, 30:7484-7494.
-
(2010)
J Neurosci
, vol.30
, pp. 7484-7494
-
-
Dube, C.M.1
Ravizza, T.2
Hamamura, M.3
-
79
-
-
39749159858
-
Early treatment suppresses the development of spike-wave epilepsy in a rat model
-
Blumenfeld H., Klein J.P., Schridde U., et al. Early treatment suppresses the development of spike-wave epilepsy in a rat model. Epilepsia 2008, 49:400-409.
-
(2008)
Epilepsia
, vol.49
, pp. 400-409
-
-
Blumenfeld, H.1
Klein, J.P.2
Schridde, U.3
-
80
-
-
71649091226
-
Favourable prognostic factors with infantile spasms
-
Riikonen R.S. Favourable prognostic factors with infantile spasms. Eur J Paediatr Neurol 2010, 14:13-18.
-
(2010)
Eur J Paediatr Neurol
, vol.14
, pp. 13-18
-
-
Riikonen, R.S.1
-
81
-
-
22544488406
-
Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex
-
Goh S., Kwiatkowski D.J., Dorer D.J., et al. Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex. Neurology 2005, 65:235-238.
-
(2005)
Neurology
, vol.65
, pp. 235-238
-
-
Goh, S.1
Kwiatkowski, D.J.2
Dorer, D.J.3
-
82
-
-
78649289488
-
Long-term outcome of 32 children with encephalopathy with status epilepticus during sleep, or ESES syndrome
-
Liukkonen E., Kantola-Sorsa E., Paetau R., et al. Long-term outcome of 32 children with encephalopathy with status epilepticus during sleep, or ESES syndrome. Epilepsia 2010, 51:2023-2032.
-
(2010)
Epilepsia
, vol.51
, pp. 2023-2032
-
-
Liukkonen, E.1
Kantola-Sorsa, E.2
Paetau, R.3
-
83
-
-
70350619353
-
The dilemma on treatment of the EEG: A justified perspective
-
Jaseja H. The dilemma on treatment of the EEG: A justified perspective. Epilepsy Behav 2009, 16:561-562.
-
(2009)
Epilepsy Behav
, vol.16
, pp. 561-562
-
-
Jaseja, H.1
-
84
-
-
77954529084
-
The natural history of epilepsy in tuberous sclerosis complex
-
Chu-Shore C.J., Major P., Camposano S., et al. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia 2010, 51:1236-1241.
-
(2010)
Epilepsia
, vol.51
, pp. 1236-1241
-
-
Chu-Shore, C.J.1
Major, P.2
Camposano, S.3
-
85
-
-
69449091966
-
Neuropsychological status at seizure onset in children: Risk factors for early cognitive deficits
-
Fastenau P.S., Johnson C.S., Perkins S.M., et al. Neuropsychological status at seizure onset in children: Risk factors for early cognitive deficits. Neurology 2009, 73:526-534.
-
(2009)
Neurology
, vol.73
, pp. 526-534
-
-
Fastenau, P.S.1
Johnson, C.S.2
Perkins, S.M.3
-
86
-
-
37249081697
-
Antiepileptic drug development in children: Considerations for a revisited strategy
-
Chiron C., Dulac O., Pons G. Antiepileptic drug development in children: Considerations for a revisited strategy. Drugs 2008, 68:17-25.
-
(2008)
Drugs
, vol.68
, pp. 17-25
-
-
Chiron, C.1
Dulac, O.2
Pons, G.3
-
87
-
-
77956632944
-
-
ILAE, Accessed July 9, 2010
-
Berg A., Berkovic S.F., Brodie M.J., et al. Revised terminology and concepts for organization of the epilepsies: Report of the commission on classification and terminology ILAE, Accessed July 9, 2010. http://www.ilae-epilepsy.org/visitors.documents/classificationsummaryreportwebaug2009.
-
Revised terminology and concepts for organization of the epilepsies: Report of the commission on classification and terminology
-
-
Berg, A.1
Berkovic, S.F.2
Brodie, M.J.3
-
88
-
-
77649319457
-
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy
-
Glauser T.A., Cnaan A., Shinnar S., et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med 2010, 362:790-799.
-
(2010)
N Engl J Med
, vol.362
, pp. 790-799
-
-
Glauser, T.A.1
Cnaan, A.2
Shinnar, S.3
-
89
-
-
0033544351
-
A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children: Lamictal Pediatric Partial Seizure Study Group
-
Duchowny M., Pellock J.M., Graf W.D., et al. A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children: Lamictal Pediatric Partial Seizure Study Group. Neurology 1999, 53:1724-1731.
-
(1999)
Neurology
, vol.53
, pp. 1724-1731
-
-
Duchowny, M.1
Pellock, J.M.2
Graf, W.D.3
-
90
-
-
0032800766
-
Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study: Gabapentin Paediatric Study Group
-
Appleton R., Fichtner K., LaMoreaux L., et al. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study: Gabapentin Paediatric Study Group. Epilepsia 1999, 40:1147-1154.
-
(1999)
Epilepsia
, vol.40
, pp. 1147-1154
-
-
Appleton, R.1
Fichtner, K.2
LaMoreaux, L.3
-
91
-
-
0033594350
-
A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children: Topiramate YP Study Group
-
Elterman R.A., Glauser T.A., Wyllie E., et al. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children: Topiramate YP Study Group. Neurology 1999, 52:1338-1344.
-
(1999)
Neurology
, vol.52
, pp. 1338-1344
-
-
Elterman, R.A.1
Glauser, T.A.2
Wyllie, E.3
-
92
-
-
18844471793
-
Adjunctive therapy with oxcarbazepine in children with partial seizures: The Oxcarbazepine Pediatric Study Group
-
Glauser T.A., Nigro M., Sachdeo R., et al. Adjunctive therapy with oxcarbazepine in children with partial seizures: The Oxcarbazepine Pediatric Study Group. Neurology 2000, 54:2237-2244.
-
(2000)
Neurology
, vol.54
, pp. 2237-2244
-
-
Glauser, T.A.1
Nigro, M.2
Sachdeo, R.3
-
93
-
-
33745665605
-
Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures
-
Glauser T.A., Ayala R., Elterman R.D., et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 2006, 66:1654-1660.
-
(2006)
Neurology
, vol.66
, pp. 1654-1660
-
-
Glauser, T.A.1
Ayala, R.2
Elterman, R.D.3
-
94
-
-
0032976081
-
A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome: Topiramate YL Study Group
-
Sachdeo R.C., Glauser T.A., Ritter F., et al. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome: Topiramate YL Study Group. Neurology 1999, 52:1882-1887.
-
(1999)
Neurology
, vol.52
, pp. 1882-1887
-
-
Sachdeo, R.C.1
Glauser, T.A.2
Ritter, F.3
-
95
-
-
0034638786
-
Stiripentol in severe myoclonic epilepsy in infancy: A randomised placebo-controlled syndrome-dedicated trial. STICLO study group
-
Chiron C., Marchand M.C., Tran A., et al. Stiripentol in severe myoclonic epilepsy in infancy: A randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 2000, 356:1638-1642.
-
(2000)
Lancet
, vol.356
, pp. 1638-1642
-
-
Chiron, C.1
Marchand, M.C.2
Tran, A.3
-
96
-
-
0031453973
-
Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome in Lamictal Lennox-Gastaut Study Group
-
Motte J., Trevathan E., Arvidsson J.F., et al. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome in Lamictal Lennox-Gastaut Study Group. N Engl J Med 1997, 337:1807-1812.
-
(1997)
N Engl J Med
, vol.337
, pp. 1807-1812
-
-
Motte, J.1
Trevathan, E.2
Arvidsson, J.F.3
-
97
-
-
0027287361
-
A controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile seizures
-
Rosman N.P., Colton T., Labazzo J., et al. A controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile seizures. N Engl J Med 1993, 329:79-84.
-
(1993)
N Engl J Med
, vol.329
, pp. 79-84
-
-
Rosman, N.P.1
Colton, T.2
Labazzo, J.3
-
98
-
-
38549178440
-
Treatment of pediatric epilepsy: European expert opinion, 2007
-
Wheless J.W., Clarke D.F., Arzimanoglou A., et al. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord 2007, 9:353-412.
-
(2007)
Epileptic Disord
, vol.9
, pp. 353-412
-
-
Wheless, J.W.1
Clarke, D.F.2
Arzimanoglou, A.3
-
99
-
-
33750366552
-
Pharmacokinetic variability of newer antiepileptic drugs: When is monitoring needed?
-
Johannessen S.I., Tomson T. Pharmacokinetic variability of newer antiepileptic drugs: When is monitoring needed?. Clin Pharmacokinet 2006, 45:1061-1075.
-
(2006)
Clin Pharmacokinet
, vol.45
, pp. 1061-1075
-
-
Johannessen, S.I.1
Tomson, T.2
-
100
-
-
33645529117
-
Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age
-
Perucca E. Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age. Clin Pharmacokinet 2006, 45:351-363.
-
(2006)
Clin Pharmacokinet
, vol.45
, pp. 351-363
-
-
Perucca, E.1
-
101
-
-
45749116975
-
Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy
-
Perucca E., Cloyd J., Critchley D., et al. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Epilepsia 2008, 49:1123-1141.
-
(2008)
Epilepsia
, vol.49
, pp. 1123-1141
-
-
Perucca, E.1
Cloyd, J.2
Critchley, D.3
-
102
-
-
0018832032
-
Pharmacokinetic aspects of anxiolytic drug therapy
-
Greenblatt D.J., Shader R.I. Pharmacokinetic aspects of anxiolytic drug therapy. Can J Neurol Sci 1980, 7:269-270.
-
(1980)
Can J Neurol Sci
, vol.7
, pp. 269-270
-
-
Greenblatt, D.J.1
Shader, R.I.2
-
103
-
-
55949109998
-
Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics
-
Riss J., Cloyd J., Gates J., et al. Benzodiazepines in epilepsy: Pharmacology and pharmacokinetics. Acta Neurol Scand 2008, 118:69-86.
-
(2008)
Acta Neurol Scand
, vol.118
, pp. 69-86
-
-
Riss, J.1
Cloyd, J.2
Gates, J.3
-
104
-
-
0026674193
-
Vigabatrin. Clinical pharmacokinetics
-
Rey E., Pons G., Olive G. Vigabatrin. Clinical pharmacokinetics. Clin Pharmacokinet 1992, 23:267-278.
-
(1992)
Clin Pharmacokinet
, vol.23
, pp. 267-278
-
-
Rey, E.1
Pons, G.2
Olive, G.3
-
105
-
-
0019797875
-
Clobazam plasma concentrations: pharmacokinetic study in healthy volunteers and data in epileptic patients
-
Tedeschi G., Riva R., Baruzzi A. Clobazam plasma concentrations: pharmacokinetic study in healthy volunteers and data in epileptic patients. Br J Clin Pharmacol 1981, 11:619-622.
-
(1981)
Br J Clin Pharmacol
, vol.11
, pp. 619-622
-
-
Tedeschi, G.1
Riva, R.2
Baruzzi, A.3
|